{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["cc293db6-e86d-4128-acb7-d82e5c48e9c2", "Q3", 69674, "NATIONAL MULTIPLE SCLEROSIS SOCIETY", 164353, "NATIONAL MULTIPLE SCLEROSIS SOCIETY", 2018, "third_quarter", "2018-10-22T11:18:28.663000-04:00", 105700.0, 0, 0, 0, "{\"url\": \"https://lda.senate.gov/api/v1/filings/cc293db6-e86d-4128-acb7-d82e5c48e9c2/\", \"filing_uuid\": \"cc293db6-e86d-4128-acb7-d82e5c48e9c2\", \"filing_type\": \"Q3\", \"filing_type_display\": \"3rd Quarter - Report\", \"filing_year\": 2018, \"filing_period\": \"third_quarter\", \"filing_period_display\": \"3rd Quarter (July 1 - Sep 30)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/cc293db6-e86d-4128-acb7-d82e5c48e9c2/print/\", \"filing_document_content_type\": \"text/html\", \"income\": null, \"expenses\": \"105700.00\", \"expenses_method\": \"a\", \"expenses_method_display\": \"Method A - Reporting amounts using LDA definitions only\", \"posted_by_name\": \"Leslie Ritter\", \"dt_posted\": \"2018-10-22T11:18:28.663000-04:00\", \"termination_date\": null, \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": null, \"registrant_address_1\": \"1100 NEW YORK AVENUE, NW, #440 E\", \"registrant_address_2\": null, \"registrant_different_address\": false, \"registrant_city\": \"WASHINGTON\", \"registrant_state\": \"DC\", \"registrant_zip\": \"20005\", \"registrant\": {\"id\": 69674, \"url\": \"https://lda.senate.gov/api/v1/registrants/69674/\", \"house_registrant_id\": 35789, \"name\": \"NATIONAL MULTIPLE SCLEROSIS SOCIETY\", \"description\": null, \"address_1\": \"1100 NEW YORK AVENUE, NW, #440 E\", \"address_2\": null, \"address_3\": null, \"address_4\": null, \"city\": \"WASHINGTON\", \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"zip\": \"20005\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"BRYANT ROBINSON\", \"contact_telephone\": \"+1 978-500-8654\", \"dt_updated\": \"2026-01-08T17:01:25.844593-05:00\"}, \"client\": {\"id\": 164353, \"url\": \"https://lda.senate.gov/api/v1/clients/164353/\", \"client_id\": 12, \"name\": \"NATIONAL MULTIPLE SCLEROSIS SOCIETY\", \"general_description\": null, \"client_government_entity\": false, \"client_self_select\": true, \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": \"DC\", \"ppb_state_display\": \"District of Columbia\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"2007-08-10\"}, \"lobbying_activities\": [{\"general_issue_code\": \"BUD\", \"general_issue_code_display\": \"Budget/Appropriations\", \"description\": \"- Department of Defense Appropriations Act, 2019, support $12 million for the MSRP.\\n- Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act, 2019, support $39.3 billion for the National Institutes of Health (NIH); $8.445 billion for the Centers for Disease Control and Prevention inclusive of $5 million to establish the National Neurological Conditions Surveillance System; $5 million for the Lifespan Respite Care Program; $150 million for the Patient-Centered Outcomes Research Institute; $454 million for the Agency for Healthcare Research and Quality; and robust funding for the SSAs administrative budget.\\n- Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2019, support - Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2019, support $3.32 billion for the Food and Drug Administration.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 51107, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"LAURA\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"WEIDNER\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 63338, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"JOHN\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"WYLAM\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 64872, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"LESLIE\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"RITTER\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 30, \"name\": \"Army, Dept of (Other)\"}, {\"id\": 136, \"name\": \"Centers For Medicare and Medicaid Services (CMS)\"}, {\"id\": 135, \"name\": \"Food & Drug Administration (FDA)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"MED\", \"general_issue_code_display\": \"Medical/Disease Research/Clinical Labs\", \"description\": \"S.2987/ H.R. 5515, National Defense Authorization Act for FY19, support funding and scope of Congressionally Directed Medical Research Programs within the Department of Defense.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 63338, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"JOHN\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"WYLAM\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 64872, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"LESLIE\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"RITTER\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 30, \"name\": \"Army, Dept of (Other)\"}, {\"id\": 136, \"name\": \"Centers For Medicare and Medicaid Services (CMS)\"}, {\"id\": 135, \"name\": \"Food & Drug Administration (FDA)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"HCR\", \"general_issue_code_display\": \"Health Issues\", \"description\": \"-Bipartisan Health Care Stabilization Act, support bipartisan efforts led by Senators Alexander and Murray to stabilize and improve the individual health insurance market while protecting people with chronic conditions.\\n-H.R. 2439/S. 1131, FAIR Drug Pricing Act, support passage.\\n- H.R. 2212/ S. 974, Creating and Restoring Equal Access To Equivalent Samples Act of 2017 (CREATES Act), support passage.\\n-H.R. 2077, Restoring Patients Voice Act, support passage.\\n-S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act, support passage.\\n-H.R. 4841/S. 2908, Standardizing Electronic Prior Authorization for Safe Prescribing Act, support passage.\\n- H.R. 2051, Fair Access for Safe and Timely Generics Act of 2017 (FAST Generics Act), support passage.\\n-H.R. 750, support passage of the Ensuring Access to Quality Complex Rehabilitation Technology Act.\\n-H.R. 1361/S. 486/H.R. 3730, support passage to protect access to complex rehabilitative technology accessories.\\n-H.R. 2535/S. 1188, Lifespan Respite Care Reauthorization Act, support reauthorization of the Lifespan Respite Care Program.\\n-HR 2575/S. 1909, Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 51107, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"LAURA\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"WEIDNER\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 66332, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"KIMBERLY\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"CALDER\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 64872, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"LESLIE\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"RITTER\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 63338, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"JOHN\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"WYLAM\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 30, \"name\": \"Army, Dept of (Other)\"}, {\"id\": 136, \"name\": \"Centers For Medicare and Medicaid Services (CMS)\"}, {\"id\": 135, \"name\": \"Food & Drug Administration (FDA)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"CIV\", \"general_issue_code_display\": \"Civil Rights/Civil Liberties\", \"description\": \"H.R. 620, ADA Education and Reform Act, oppose passage.\", \"foreign_entity_issues\": \"No foreign interests.\", \"lobbyists\": [{\"lobbyist\": {\"id\": 51107, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"LAURA\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"WEIDNER\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 30, \"name\": \"Army, Dept of (Other)\"}, {\"id\": 136, \"name\": \"Centers For Medicare and Medicaid Services (CMS)\"}, {\"id\": 135, \"name\": \"Food & Drug Administration (FDA)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"TRA\", \"general_issue_code_display\": \"Transportation\", \"description\": \"-H.R. 5004/S. 1318, Air Carrier Access Amendments Act, support passage.\\n-Reauthorization of the Federal Aviation Administration, support provisions to improve air travel for passengers with disabilities.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 51107, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"LAURA\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"WEIDNER\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 30, \"name\": \"Army, Dept of (Other)\"}, {\"id\": 136, \"name\": \"Centers For Medicare and Medicaid Services (CMS)\"}, {\"id\": 135, \"name\": \"Food & Drug Administration (FDA)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"MMM\", \"general_issue_code_display\": \"Medicare/Medicaid\", \"description\": \"-H.R. 750, support passage of the Ensuring Access to Quality Complex Rehabilitation Technology Act.\\n-H.R. 1361/S. 486/H.R. 3730, support passage to protect access to complex rehabilitative technology accessories.\\n-HR 2575/S. 1909, Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 63338, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"JOHN\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"WYLAM\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 66332, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"KIMBERLY\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"CALDER\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 51107, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"LAURA\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"WEIDNER\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 30, \"name\": \"Army, Dept of (Other)\"}, {\"id\": 136, \"name\": \"Centers For Medicare and Medicaid Services (CMS)\"}, {\"id\": 135, \"name\": \"Food & Drug Administration (FDA)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}", "DC", "US", 35789, "DC", "DC", "US", "US", null, 0, 0, 100161, null, "normalized_name_dc_fallback", 0.8]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json", "registrant_state", "registrant_country", "registrant_house_id", "client_state", "client_ppb_state", "client_country", "client_ppb_country", "client_general_description", "client_government_entity", "affiliated_org_count", "client_entity_id", "client_government_unit_id", "client_match_method", "client_match_confidence"], "primary_keys": ["filing_uuid"], "primary_key_values": ["cc293db6-e86d-4128-acb7-d82e5c48e9c2"], "units": {}, "query_ms": 1.2185670202597976, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}